| Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities E O'Reilly, HA Zeinabad, E Szegezdi Blood Reviews 50, 100850, 2021 | 53 | 2021 |
| The Janus face of death receptor signaling during tumor immunoediting E O’Reilly, A Tirincsi, SE Logue, E Szegezdi Frontiers in Immunology 7, 446, 2016 | 51 | 2016 |
| Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML E O’Reilly, SPS Dhami, DV Baev, C Ortutay, A Halpin-McCormick, ... Scientific Reports 8 (1), 15752, 2018 | 36 | 2018 |
| Tc buster transposon engineered CLL-1 CAR-NK cells efficiently target acute myeloid leukemia M Gurney, E O'Reilly, S Corcoran, S Brophy, D Hardwicke, J Krawczyk, ... Blood 138, 1725, 2021 | 11 | 2021 |
| Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells M Gurney, E O'Reilly, S Corcoran, S Brophy, J Krawczyk, NM Otto, ... Cytotherapy 24 (11), 1087-1094, 2022 | 8 | 2022 |
| Recreating the bone marrow microenvironment to model leukemic stem cell quiescence E O’Reilly, HA Zeinabad, C Nolan, J Sefy, T Williams, M Tarunina, ... Frontiers in cell and developmental biology 9, 662868, 2021 | 8 | 2021 |
| Molecular targets for novel drug development in pancreatic cancer E O’Reilly, C Santocanale, É Szegezdi Ann. Cancer Res 2 (3), 1-11, 2015 | 4 | 2015 |
| Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia S Ennis, A Conforte, E O’Reilly, JS Takanlu, T Cichocka, SP Dhami, ... Iscience 26 (6), 2023 | 1 | 2023 |
| TRAIL Engineering Enhances Expanded Cord Blood NK Cell Anti-Leukemic Activity M Gurney, M Twohig, DG Helvaci, E O'Reilly, S Brophy, J Krawczyk, ... Blood 140 (Supplement 1), 10249-10250, 2022 | | 2022 |
| Single-cell characterisation of the hematopoietic bone marrow interactome in health and disease S Ennis, A Conforte, E O’Reilly, T Cichocka, S Pal Dhami, P Nicholson, ... bioRxiv, 2022.05. 13.491790, 2022 | | 2022 |
| Mechanisms of bone marrow-mediated drug resistance in acute myeloid leukaemia E O'Reilly NUI Galway, 2020 | | 2020 |
| Single-cell characterisation of the hematopoietic bone S Ennis, A Conforte, E O’Reilly, T Cichocka, SP Dhami, P Nicholson, ... bone 1, 10, 0 | | |
Michael O'DwyerHaematologyVerified email at nuigalway.ie
